Co-opting endogenous microRNAs for therapy (Q44843194)

6 December 2017

title

Co-opting endogenous microRNAs for therapy (English)

1 reference

6 December 2017

1 reference

Christopher E Pearson

series ordinal

1 reference

6 December 2017

language of work or name

English

0 references

publication date

6 July 2012

1 reference

6 December 2017

1 reference

6 December 2017

1 reference

6 December 2017

1 reference

6 December 2017

page(s)

1011-1012

1 reference

Repeat Associated Non-ATG Translation Initiation: One DNA, Two Transcripts, Seven Reading Frames, Potentially Nine Toxic Entities!

6 December 2017

cites work

1 reference

The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing

21 January 2018

1 reference

Novel role for RNA-binding protein CUGBP2 in mammalian RNA editing. CUGBP2 modulates C to U editing of apolipoprotein B mRNA by interacting with apobec-1 and ACF, the apobec-1 complementation factor

21 January 2018

1 reference

Coupled mRNA stabilization and translational silencing of cyclooxygenase-2 by a novel RNA binding protein, CUGBP2

21 January 2018

1 reference

Dysregulation and cellular mislocalization of specific miRNAs in myotonic dystrophy type 1

21 January 2018

1 reference

Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3.

21 January 2018

1 reference

The microRNA miR-34 modulates ageing and neurodegeneration in Drosophila

21 January 2018

1 reference

Huntington's disease: progress toward effective disease-modifying treatments and a cure

21 January 2018

1 reference

Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi

21 January 2018

1 reference

MicroRNA-196: critical roles and clinical applications in development and cancer

21 January 2018

1 reference

Molecular pathophysiology and disease-modifying therapies for spinal and bulbar muscular atrophy.

21 January 2018

1 reference

Viral delivery of miR-196a ameliorates the SBMA phenotype via the silencing of CELF2

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22772549

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NM.2864

1 reference

6 December 2017

1 reference